Binding of complement proteins C1q and C4bp to serum amyloid P component (SAP) in solid contra liquid phase

Scandinavian Journal of Immunology

Volumn 44, Issue 4, 1996, Pages 401-407

  Sørensen, I Juul ^a   Nielsen, E Holm ^a   Andersen, O ^b   Danielsen, B ^a   Svehag, S E ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4B; SERUM AMYLOID P;

ARTICLE; COMPLEMENT ACTIVATION; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOELECTROPHORESIS; PRIORITY JOURNAL;

EID: 10144250991     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-326.x     Document Type: Article

References (19)

1. Breathnach SM, Melrose SM, Bhogal B et al. Amyloid P component is located on elactic fibre microfibrils in normal human tissue. Nature 1981;293:652-4.
2. Dyck RF, Lockwood CM, Kershaw M et al. Amyloid P-component is a constituent of normal human glomerular basement membrane. J Exp Med 1980;152:1162-74.
3. Pepys MB. Amyloidosis. In: Frank MM, Austen KF, Claman HN, Unanue ER, eds. Immunological Diseases. Boston: Little, Brown, 1994:637-55.
4. Hawkins PN, Lavender JP, Myers MJ, Pepys MB. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component. Lancet 1988;1: 1413-18.
5. Duong T, Pommier EC, Scheibel AB. Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol 1989;78:429-37.
6. Kaluria RN, Kroon SN. Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer's disease. Biochem Biophys Res Commun 1992;186: 461-6.
7. Eikelenboom P, Hack CE, Rozemuller JM, Stam FC. Complement activation in amyloid plaques in Alzheimer's dementia. Virch Arch B Cell Palhol 1989;56:259-62.
8. Sorensen IJ, Andersen O, Nielsen EH, Svehag SE. Native human serum amyloid P component is a single pentamer. Scand J Immunol 1995;41:263-7.
9. Andersen O, Nielsen EH, Storgaard P et al. Biochemical and ultrastructural studies of the C-type lectin bovine conglutinin. J Struct Biol 1992;109:201-7.
10. Cooper NR, Ziccardi RJ. Amyloid P component (C1t) and complement: lack of physical or functional relationship. Molec Immunol 1979;16:821-7.
11. Bristow CL, Boackle RJ. Evidence for the binding of human amyloid P component to C1q and Fab., Molec Immunol 1986;23:1045-52.
12. Ying SC, Gewurz AT, Jiang H, Gewurz H. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14 26 and 76 92 of the A chain collagen-like region of C1q. J Immunol 1993;150:169-76.
13. Potter BJ, Elias E, Thomas HC, Sherlock S. Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis. Gastroenterology 1980;78:1034-42.
14. Sjöholm AG, Mårtensson U, Laurell A-B. C1 dissociation in serum: estimation of free C1q by electroimmunoassay. Acta Path Microbiol Immunol Scand Sect C 1985;93:191-8.
15. Hicks PS, Saunero-Nava L, Du Clos TW, Mold C. Serum amyloid P component binds to histones and activates the classical complement pathway. J Immunol 1992;149:3689-94.
16. Pepys MB; Butler PJG. Serum amyloid P component is the major calcium-dependent DNA binding protein in serum. Biochem Biophys Res Commun 1987;148:308-13.
17. Schwalbe RA, Dahlbäck B, Nelsestuen GE. Independent association of serum amyloid P component, protein S, and complement C4b with complement C4b-binding protein and subsequent association of the complex with membranes. J Biol Chem 1990; 265:21749-57.
18. deFrutos PG, Härdig Y, Dahlbäck B. Serum amyloid P component binding to C4b-binding protein. J Biol Chem 1995;270: 26950-5.
19. Schwalbe RA, Dahlbäck B, Nelsestuen GE. Heparin influence on the complex of serum amyloid P component and complement C4b-binding protein. J Biol Chem 1991;20:12896-901.